Company name change reflects the significant product portfolio expansion for world-leading positive displacement pump manufacturer
Watson-Marlow Pumps Group announced today that it has changed its name to Watson-Marlow Fluid Technology Group to better reflect the evolution of the company from its roots as a manufacturer of peristaltic pumps and tubing, to its current position as a world leader in fluid path technology.
Watson-Marlow Fluid Technology Group, which has a global network of operations including seven factories and 28 direct sales offices, is part of the Spirax-Sarco Engineering Group plc and is headquartered in Falmouth, UK.
The company now encompasses seven distinct brands which, combined, deliver a complete suite of fluid technology solutions to the biopharmaceutical , chemical process, food and beverage, mining and environmental market sectors. The name change follows the recent acquisition of BioPure, which signaled the company’s strategic move to offer a wider range of solutions to the biotechnology and pharmaceutical markets.
Reflection of Today’s Portfolio
Commenting on the name change, Watson-Marlow Fluid Technology Group's President, Jay Whalen, said: “Our new name unifies our growing portfolio of fluid path technologies, it is an expression of what we deliver today, and a reflection of the growing portfolio of businesses and opportunities that sit within our group. Our sector market focus, combined with the recent acquisition of BioPure gave us the opportunity to rethink the way we present ourselves to the market. We can no longer simply be defined as a pump or tubing company: we now offer customers a much more holistic offering”.
The company name change is part of a five-pronged growth strategy, which includes targeted investment in selective product development and market sector diversification. This is highlighted by the additions of MasoSine (sinusoidal pumps for the food and beverage sector), Flexicon (filling and vial capping systems used in the aseptic filling sector), BioPure (single-use tubing connection systems as used in the biopharmaceutical sector) and non-pump transfer tubing development.
Mr Whalen concludes: “This re-presentation of our company cements our position as a business that never stands still and is committed to embracing change and innovation. This is what our customers deserve and expect from a business such ours. I am delighted we can demonstrate this ‘evolution’ in such a positive and sustainable way”.